日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metabolic surgery mitigates early kidney injury in obese youth with diabetes by suppressing mTORC1/JAK/STAT signaling

代谢手术通过抑制mTORC1/JAK/STAT信号通路减轻肥胖糖尿病青少年早期肾损伤

Naik, Abhijit S; Alakwaa, Fadhl M; Nair, Viji; McCown, Phillip J; Schaub, Jennifer A; Otto, Edgar A; Menon, Rajasree; Annese, Francesca; Choi, Ye Ji; Hampson, Hailey E; Inge, Thomas H; Hartman, John; Eddy, Sean; Smith, Cathy; Hodgin, Jeffrey B; Inoki, Ken; Srivastava, Swayam Prakash; Al-Fagih, Kareem; Yoshida, Shota; Goodrich, Jesse A; Cree, Melanie G; Narongkiatikhun, Phoom; Yuan, Long; Tommerdahl, Kalie L; Prasad, Pottumarthi; van Raalte, Daniël H; Kelsey, Megan M; Ryder, Justin R; Dobbs, Tyler J; Ladd, Patricia; Pennathur, Subramaniam; Nelson, Robert G; Okabayashi, Yusuke; Puelles, Victor G; Ferrence-Salo, Jenna; Beamish, Jeffrey A; Brosius, Frank C; Nadeau, Kristen J; Pyle, Laura; Kretzler, Matthias; Bjornstad, Petter

Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies

SGLT2抑制剂与GLP-1受体激动剂联合治疗2型糖尿病患者的有效性和安全性:队列研究的系统评价和荟萃分析

Colombijn, Julia M T; de Leijer, Jan F; Visseren, Frank L J; Verhaar, Marianne C; van Raalte, Daniël H; Sattar, Naveed; Vernooij, Robin W M; van Sloten, Thomas T

The Gut-Kidney Axis and Effect on GFR

肠-肾轴及其对肾小球滤过率的影响

Hanssen, Nordin M J; van Raalte, Daniël H

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks

SURMOUNT-1 研究中,Tirzepatide 与肥胖和糖尿病前期参与者肾脏参数的相关性(176 周)

Heerspink, Hiddo J L; van Raalte, Daniel H; Tuttle, Katherine; Cherney, David Z I; Bjornstad, Petter; Cao, Dachuang; Dimitriadis, Georgios K; Linetzky, Bruno; Jouravskaya, Irina; Bunck, Mathijs C; Griffin, Ryan; Gerber, Claire

GLP-1-based therapeutics for cardiorenal protection in metabolic diseases

基于GLP-1的疗法在代谢性疾病中发挥心肾保护作用

Apperloo, Ellen M; Heerspink, Hiddo J L; van Raalte, Daniël H; Muskiet, Marcel H A

Insulin Sensitivity and Associated Plasma Proteomics During Sex Hormone Therapy

性激素治疗期间胰岛素敏感性及相关血浆蛋白质组学

van Eeghen, Sarah A; Pyle, Laura; Narongkiatikhun, Phoom; Choi, Ye Ji; Vosters, Taryn G; van Valkengoed, Irene G M; Bjornstad, Petter; Siegelaar, Sarah E; Nokoff, Natalie J; den Heijer, Martin; van Raalte, Daniël H

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis

SGLT抑制剂的作用机制和生理介质:系统评价和MOSAIC合作荟萃分析方案

Kugathasan, Luxcia; Nardone, Massimo; Muskiet, Marcel H A; Diaz Martinez, Juan Pablo; Lovblom, Leif Erik; Orchanian-Cheff, Ani; Nielsen, Steffen; Rotbain, Viktor; Kazup, Agota; Cersosimo, Eugenio; Gullaksen, Soren; Vernstrom, Liv; van Baar, Michael J B; van Bommel, Erik; Kannenkeril, Dennis; Scholtes, Rosalie; Hesp, Anne; Mosterd, Charlotte; Touw, Daan J; Lambers Heerspink, Hiddo; Krebbe, Merle; Joles, Jaap; Kvitne, Kine; Laugesen, Esben; Mose, Frank; Mårup, Frederik Husum; Nieuwdorp, Max; Geist, Barbara; Maruyama, Shoichi; Kato, Sawako; Kalambokis, Georgios; Tsiakas, Ilias; Jensen, Jesper; Schou, Morten; Omar, Massar; Kistorp, Caroline Michaela; Perna, Annalisa; Ruggenenti, Piero; Persson, Frederik; Schmieder, Roland; Singh, Sunita; van Raalte, Daniel H; Cherney, David; Srinivasan Sridhar, Vikas

GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity

GLP-1受体激动剂在治疗2型糖尿病和肥胖症合并慢性肾病中的应用

Cooper, Mark E; van Raalte, Daniël H

Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes

替拉帕肽治疗肥胖(伴或不伴2型糖尿病)患者的肾功能参数

Heerspink, Hiddo J L; Friedman, Allon N; Bjornstad, Petter; van Raalte, Daniel H; Cherney, David; Cao, Dachuang; Garcia-Pérez, Luis-Emilio; Stefanski, Adam; Turfanda, Ibrahim; Bunck, Mathijs C; Benabbad, Imane; Griffin, Ryan; Piras de Oliveira, Carolina

Authors' Reply: Tirzepatide and Kidney Protection in Obesity: Unanswered Questions

作者回复:替拉帕肽与肥胖症肾脏保护:未解答的问题

Heerspink, Hiddo J L; Bjornstad, Petter; Cherney, David; van Raalte, Daniel H